查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1937930

全球獸醫腫瘤市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Veterinary Oncology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計獸醫腫瘤市場將從 2025 年的 8.4 億美元成長到 2034 年的 23.8 億美元，2026 年至 2034 年的複合年成長率為 12.22%。

隨著人們對寵物健康的日益關注以及動物癌症發病率的不斷上升，獸醫腫瘤市場正經歷著強勁的成長。飼主主人越來越傾向於為他們心愛的寵物尋求先進的治療方法，因此對獸醫腫瘤服務和產品的需求也不斷擴大。人們對寵物健康的日益關注，以及獸醫學的進步，正在推動用於治療動物癌症的創新治療方法和診斷工具的研發。隨著獸醫診所將腫瘤患者的專科護理置於優先地位，獸醫腫瘤市場預計將進一步發展。

技術創新在塑造獸醫腫瘤市場的未來前景方面發揮關鍵作用。磁振造影（MRI）和電腦斷層掃描）等影像技術的創新提高了寵物腫瘤的檢測和後續觀察能力，從而實現了更早期、更準確的診斷。此外，標靶治療和免疫療法的發展正在革新獸醫癌症治療，為飼主提供更有效、更微創的選擇。隨著製造商和獸醫專業人士在研發方面持續合作，預計獸醫腫瘤市場將進一步採用先進的治療方法和技術。

此外，人們對個人化醫療和寵物整體護理方法的日益關注正在影響獸醫腫瘤市場。隨著寵物飼主對寵物健康了解的不斷深入，他們對能夠充分考慮​​每位患者需求和意願的客製化治療方案的需求也日益成長。這一趨勢正在推動整合腫瘤服務的發展，這些服務將傳統療法與治療方法管理和疼痛管理等輔助療法相結合。隨著市場的不斷發展，技術、個人化護理和整體護理方法的融合將成為獸醫腫瘤領域成功的關鍵驅動力。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球獸醫腫瘤市場（依動物類型分類）

  • 市場分析、洞察與預測
  • 伴侶動物（馬、狗、貓）
  • 家畜

5. 全球獸醫腫瘤市場（依治療方法）

  • 市場分析、洞察與預測
  • 化療
  • 聯合治療
  • 免疫療法
  • 標靶治療

6. 全球獸醫腫瘤市場依給藥途徑分類

  • 市場分析、洞察與預測
  • 口服
  • 靜脈注射

7. 全球獸醫腫瘤市場（按應用分類）

  • 市場分析、洞察與預測
  • 犬淋巴瘤
  • 骨癌（OSA）
  • 肥大細胞瘤
  • 黑色素瘤
  • 其他

8. 全球獸醫腫瘤市場（依通路分類）

  • 市場分析、洞察與預測
  • 醫院藥房
  • 政府機構
  • 零售藥房

9. 全球獸醫腫瘤市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第11章 公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zoetis Inc
    • Elanco
    • Boehringer Ingelheim International GmbH
    • Merck Animal Health
    • Varian Medical Systems
    • Accuray Incorporated
    • PetCure Oncology
    • AB Science
    • Karyopharm Therapeutics Inc
    • Regeneus Ltd
    • Morphogenesis Inc
    • VetDC
    • Zenoaq
    • Rhizen Pharmaceutical SA
    • AdvaVet Inc
簡介目錄
Product Code: VMR11218350

The Veterinary Oncology Market size is expected to reach USD 2.38 Billion in 2034 from USD 0.84 Billion (2025) growing at a CAGR of 12.22% during 2026-2034.

The Veterinary Oncology Market is experiencing robust growth as the awareness of pet health and the prevalence of cancer in animals continue to rise. As pet owners increasingly seek advanced treatment options for their beloved companions, the demand for veterinary oncology services and products is expanding. The growing focus on pet wellness, coupled with advancements in veterinary medicine, is driving the development of innovative therapies and diagnostic tools for cancer treatment in animals. As veterinary practices prioritize specialized care for oncology patients, the market for veterinary oncology is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the veterinary oncology market. Innovations in diagnostic imaging, such as MRI and CT scans, are enhancing the ability to detect and monitor tumors in pets, leading to earlier and more accurate diagnoses. Additionally, the development of targeted therapies and immunotherapies is revolutionizing cancer treatment in veterinary medicine, offering more effective and less invasive options for pet owners. As manufacturers and veterinary professionals continue to collaborate on research and development, the veterinary oncology market is likely to see increased adoption of advanced treatment modalities and technologies.

Moreover, the growing emphasis on personalized medicine and holistic approaches to pet care is influencing the veterinary oncology market. As pet owners become more informed about their pets' health, there is a rising demand for tailored treatment plans that consider individual patient needs and preferences. This trend is driving the development of integrative oncology services that combine conventional treatments with complementary therapies, such as nutrition and pain management. As the market continues to evolve, the integration of technology, personalized care, and holistic approaches will be key drivers of success in the veterinary oncology sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal Type

  • Companion Animal (Equine, Canine, and Feline)
  • Livestock Animal

By Therapy Type

  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy

By Mode of Administration

  • Oral
  • Intravenous

By Application

  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies

COMPANIES PROFILED

  • Zoetis Inc, Elanco, Boehringer Ingelheim International GmbH, Merck Animal Health, Varian Medical Systems, Accuray Incorporated, PetCure Oncology, AB Science, Karyopharm Therapeutics Inc, Regeneus Ltd, Morphogenesis Inc, VetDC, Zenoaq, Rhizen Pharmaceutical SA, AdvaVet Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY ONCOLOGY MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Animal Type
  • 4.2. Companion Animal (Equine, Canine, and Feline) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Livestock Animal Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY ONCOLOGY MARKET: BY THERAPY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Therapy Type
  • 5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Combination Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Targeted Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY ONCOLOGY MARKET: BY MODE OF ADMINISTRATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Mode Of Administration
  • 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Canine Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Osteosarcoma (OSA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Mast Cell Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Melanoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY ONCOLOGY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Distribution Channel
  • 8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Government Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY ONCOLOGY MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Animal Type
    • 9.2.2 By Therapy Type
    • 9.2.3 By Mode Of Administration
    • 9.2.4 By Application
    • 9.2.5 By Distribution Channel
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Animal Type
    • 9.3.2 By Therapy Type
    • 9.3.3 By Mode Of Administration
    • 9.3.4 By Application
    • 9.3.5 By Distribution Channel
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Animal Type
    • 9.4.2 By Therapy Type
    • 9.4.3 By Mode Of Administration
    • 9.4.4 By Application
    • 9.4.5 By Distribution Channel
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Animal Type
    • 9.5.2 By Therapy Type
    • 9.5.3 By Mode Of Administration
    • 9.5.4 By Application
    • 9.5.5 By Distribution Channel
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Animal Type
    • 9.6.2 By Therapy Type
    • 9.6.3 By Mode Of Administration
    • 9.6.4 By Application
    • 9.6.5 By Distribution Channel
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY ONCOLOGY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Zoetis Inc
    • 11.2.2 Elanco
    • 11.2.3 Boehringer Ingelheim International GmbH
    • 11.2.4 Merck Animal Health
    • 11.2.5 Varian Medical Systems
    • 11.2.6 Accuray Incorporated
    • 11.2.7 PetCure Oncology
    • 11.2.8 AB Science
    • 11.2.9 Karyopharm Therapeutics Inc
    • 11.2.10 Regeneus Ltd
    • 11.2.11 Morphogenesis Inc
    • 11.2.12 VetDC
    • 11.2.13 Zenoaq
    • 11.2.14 Rhizen Pharmaceutical SA
    • 11.2.15 AdvaVet Inc